AGIO
Agios Pharmaceuticals, Inc.
31.90$
+0.4%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +152.1% | -53.6% | +8.0% | +0.1% | -13.7% | -10.6% | +361.2% | -62.4% | +97.5% | +0.7% | -13.3% | -0.8% | +36.2% | +145.8% | -57.1% | -7.1% | +26.9% | -6.0% | -9.8% | -100.0% | – | +2,009,076.5% | +570.9% | -37.0% | +22.6% | +30.1% | +19.7% | +10.2% | -4.0% | +15.3% | +5.2% | +4.1% | +19.7% | -18.7% | +42.7% | +3.4% | +55.0% | +3.9% | +115.7% | – | |
| – | +6.7% | -3.0% | +27.2% | -8.6% | +5.9% | +1.3% | +10.9% | -99.2% | +1.0% | -52.4% | -9.3% | +29.7% | -27.0% | +85.7% | +26.6% | -5.5% | +50.3% | +410.5% | -4.1% | -2.5% | +0.7% | +13.9% | -0.8% | -3.8% | -4.4% | +3.4% | +12.5% | -88.6% | +214.2% | -0.7% | +56.4% | -74.6% | +60.9% | +87.5% | +25.3% | +3.1% | +3.0% | -14.7% | +11.7% | – | |
| – | – | – | – | – | – | – | – | – | +102.1% | +2.0% | -13.3% | -1.1% | +37.2% | +146.3% | -57.6% | -7.1% | +26.5% | -111.4% | – | – | – | – | – | -500.8% | – | – | +73.8% | +492.5% | -24.4% | +21.5% | -11.1% | +48.0% | +15.8% | -32.8% | +49.2% | +3.5% | +71.2% | +7.4% | +131.1% | – | |
| – | +6.7% | -3.0% | +27.2% | -8.6% | +5.9% | +1.3% | +10.9% | -4.8% | +13.6% | +1.9% | +12.3% | -5.3% | +4.5% | -14.1% | -0.4% | -1.5% | +6.9% | -42.4% | +8.1% | +3.6% | +15.1% | -4.9% | +6.8% | -12.8% | +8.7% | -4.3% | +2.4% | +22.0% | -7.0% | -11.6% | +12.7% | -4.4% | +14.3% | -13.7% | +26.9% | -5.8% | +1.6% | -8.1% | +26.3% | – | |
| – | +29.7% | -3.6% | +8.8% | +8.2% | +30.1% | +8.1% | +8.5% | +16.8% | +64.6% | -37.9% | +1.9% | +1.9% | +5.5% | +10.5% | -6.6% | -3.1% | +14.2% | -79.6% | +259.3% | -7.1% | +16.1% | 0.0% | -10.3% | +3.0% | +12.5% | -13.4% | +7.2% | -15.1% | +36.7% | -12.2% | +14.6% | +8.4% | +34.1% | -19.7% | +10.5% | -10.0% | +25.0% | -6.4% | +6.7% | – | |
| – | +10.4% | -3.1% | +23.7% | -5.8% | +10.6% | +2.8% | +10.3% | +0.3% | +10.6% | +1.4% | +9.7% | -3.6% | +4.7% | -8.0% | -2.2% | -1.9% | +8.9% | -36.3% | +0.2% | +0.1% | +15.8% | -3.5% | +1.3% | -8.6% | +10.2% | -7.5% | +3.9% | +13.5% | +3.5% | -11.8% | +13.3% | -0.3% | +21.2% | -16.0% | +20.8% | -7.2% | +9.2% | -7.5% | +18.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +36.1% | -4.6% | +72.3% | +23.8% | -1.9% | +72.7% | +31.9% | +7.0% | +1.4% | -3.4% | -9.4% | -27.6% | +24.0% | -18.0% | -30.1% | +376.2% | -38.4% | -94.3% | -72.9% | +178.3% | +29.7% | +109.0% | +158.4% | +112.9% | +69.9% | +47.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -321.8% | – | – | – | – | – | – | -110.5% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -37.0% | -269.1% | – | – | +48.5% | -85.3% | -2,019.0% | – | – | – | – | – | – | – | -4.0% | – | – | -116.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -321.8% | – | – | – | – | – | – | -110.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -287.3% | – | – | – | – | – | – | -110.4% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.